ETN-003

N/A

Report date: 2022/01/28 17:39:36
NME

Base Information

Drug NameETN-003
Drug Alias NameETN-003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursLeukemia, Myeloid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesEternity Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesEternity Bioscience Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursLeukemia, Myeloid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A